Loading viewer...
investor_presentation
Format: PDF investor_presentation
Marvell Technology, Inc. Second Quarter of Fiscal Year 2022 August 26, 2021
Marvell Technology, Inc.
Second Quarter of Fiscal Year 2022
August 26, 2021© 2021 Marvell confidential. All rights reserved. 2Discussion of Non -GAAP Financial Measures
Non-GAAP financial measures exclude the effect of share- based compensation expense, amortization of the inventory fair value adj ustment
associated with acquisition, amortization of acquired intangible assets, acquisition and divestiture -related costs, restructurin g and other related
charges (including, but not limited to, asset impairment charges, employee severance costs, and facilities related charges), resolution of legal
matters, and certain expenses and benefits that are driven primarily by discrete events that management does not consider to be directly related to
Marvell's core business.
Marvell uses a non- GAAP tax rate to compute the non- GAAP tax provision. This non- GAAP tax rate is based on Marvell's estimated annual GAAP
income tax forecast, adjusted to account for items excluded from GAAP income in calculating Marvell's non- GAAP income, as well as the effects of
significant non- recurring and period specific tax items which vary in size and frequency. Marvell's non- GAAP tax rate is determi ned on an annual
basis and may be adjusted during the year to take into account events that may materially affect the non- GAAP tax rate such as t ax law changes;
significant changes in Marvell's geographic mix of revenue and expenses; or changes to Marvell's corporate structure. For the second quarter of
fiscal 2022, a non- GAAP tax rate of 5.0% has been applied to the non- GAAP financial results.
Marvell believes that the presentation of non- GAAP financial measures provides important supplemental information to management and investors
regarding financial and business trends relating to Marvell's financial condition and results of operations. While Marvell us es non-GAAP financial
measures as a tool to enhance its understanding of certain aspects of its financial performance, Marvell does not consider these measures to be a
substitute for, or superior to, financial measures calculated in accordance with GAAP. Consistent with this approach, Marvell believes that disclosing
non-GAAP financial measures to the readers of its financial statements provides such readers with useful supplemental data that, while not a
substitute for GAAP financial measures, allows for greater transparency in the review of its financial and operational perfor mance. © 2021 Marvell confidential. All rights reserved. 3Discussion of Non -GAAP Financial Measures (continued)
Externally, management believes that investors may find Marvell's non- GAAP financial measures useful in their assessment of Marv ell's operating
performance and the valuation of Marvell. Internally, Marvell's non- GAAP financial measures are used in the following areas:
• Management’s evaluation of Marvell’s operating performance;
• Management’s establishment of internal operating budgets;
Preview truncated — download the full document for the complete content.
presentation
investor_presentation
KKR & Co
Varian Medical Systems Investor Presentation — April 2019
investor_presentationinvestor_presentation
33 Pages
Varian Medical Systems, Inc.